Effect of Sequential Nephron Blockade versus Dual Renin-Angiotensin System Blockade Plus Bisoprolol in the Treatment of Resistant Hypertension, a Randomized Controlled Trial (Resistant Hypertension on Treatment - ResHypOT)

INTRODUCTION: Hypertension is the most important modifiable risk factor for cardiovascular disease and a leading public health concern. OBJECTIVES: The primary aim was to compare sequential nephron blockade (SNB) versus dual renin-angiotensin system blockade (DRASB) plus bisoprolol in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Cestario, Elizabeth do Espirito Santo, Vilela-Martin, Jose Fernando, Cosenso-Martin, Luciana Neves, Rubio, Tatiane Azevedo, Uyemura, Jessica Rodrigues Roma, da Silva Lopes, Valquiria, Fernandes, Letícia Aparecida Barufi, Bonalume Tacito, Lucia Helena, Moreno Junior, Heitor, Yugar-Toledo, Juan Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762262/
https://www.ncbi.nlm.nih.gov/pubmed/36545494
http://dx.doi.org/10.2147/VHRM.S383007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762262/
https://www.ncbi.nlm.nih.gov/pubmed/36545494
http://dx.doi.org/10.2147/VHRM.S383007

Ejemplares similares